| For: | Deng ZH, Li X, Liu L, Zeng HM, Chen BF, Peng J. Role of gut microbiota and Helicobacter pylori in inflammatory bowel disease through immune-mediated synergistic actions. World J Gastroenterol 2024; 30(47): 5097-5103 [PMID: 39713161 DOI: 10.3748/wjg.v30.i47.5097] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i47/5097.htm |
| Number | Citing Articles |
| 1 |
Xi Chen, Zibo Lin, Nanxi Wang, Yujie Zhou, Lei Cheng, Biao Ren. Helicobacter pylori-derived outer membrane vesicles: Pathogenic roles, microbiota interactions, and biomedical applications. Journal of Advanced Research 2025; doi: 10.1016/j.jare.2025.09.055
|
| 2 |
Abdullah D. Alotaibi. C-Reactive Protein Levels in Patients with Isolated Inflammatory Bowel Disease (Crohn’s Disease and Ulcerative Colitis) and Coexisting H. pylori Infection and IBD: A Comparative Study. Inflammatory Intestinal Diseases 2025; 10(1): 318 doi: 10.1159/000548449
|
| 3 |
Cui-Hong Tian, Xue-Rui Tan. Gut microbiome and cardiovascular disease: Evidence, mechanism, challenge, and future strategies. World Chinese Journal of Digestology 2025; 33(8): 631 doi: 10.11569/wcjd.v33.i8.631
|
| 4 |
Chao Xiong, Zhuo Chen, Xian Wu, Caiyun Zhang, Zijun Yuan, Xiang Wang, Zhangang Xiao, Yu Chen, Shuai Deng, Xu Wu, Mingxing Li, Fukuan Du, Yueshui Zhao, Xiaobing Li, Xi He, Jing Shen. The impact of multidimensional interactions among Helicobacter pylori infection, tumor microenvironment, and gut microbiota on gastric cancer immune response. European Journal of Pharmacology 2026; 1011: 178401 doi: 10.1016/j.ejphar.2025.178401
|
